A groundbreaking trial for a prostate cancer treatment with fewer side-effects has launched in the UK, researchers have said.
Backed by the Government-funded National Institute for Health and Care Research (NIHR), the trial will examine whether Aquablation – a therapy using robotics, AI and real-time imaging – works as well or better than traditional surgery, known as radical prostatectomy.
